Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Citurgia Biochemicals Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Citurgia Biochemicals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Citurgia Biochem - Results-Delay in Financial Results

    27 Feb 2025, 5:31PM Unaudited financial result for the quarter ended on 31.12.2024
  • Citurgia Biochem - Results-Delay in Financial Results

    27 Feb 2025, 5:27PM Unaudited Financial Result for the quarter ended on 31.12.2024
  • Citurgia Biochem - Board Meeting Intimation for CONSIDER AND APPROVE UNAUDITED FINANCIAL RESULT FOR THE QUARTER ENDED ON 31.1

    10 Feb 2025, 5:57PM CITURGIA BIOCHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consid
  • Citurgia Biochem - Appointment of Company Secretary and Compliance Officer

    6 Feb 2025, 3:18PM Appointment of Company Secretary
  • Citurgia Biochem - Announcement under Regulation 30 (LODR)-Change in Registered Office Address

    4 Feb 2025, 5:48PM Change in Registered office Adderss
  • Citurgia Biochem has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024

    21 Jan 2025, 5:20PM As of December 2024, 99.67% is owned by Promoters and 0.33% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 0.04% and For

Key fundamentals

Evaluate the intrinsic value of Citurgia Biochemicals Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 0.201 0.4586 0.8388 1.2429 1.8429
Liabilities 0.201 0.4586 0.8388 1.2429 1.8429
Equity 26.419 26.419 26.419 26.419 26.419
Gross Profit -0.2498 -0.2104 -0.1784 -0.3729 -0.1177
Net Profit -0.4755 -0.4362 -0.4041 -0.6119 -0.3962
Cash From Operating Activities -0.1416 -0.0675 -0.0285 -0.148 -0.1128
NPM(%) 0 0 0 0 0
Revenue 0 0 0 0 0
Expenses 0.2498 0.2104 0.1784 0.3729 0.1177
ROE(%) 5.24 4.81 4.45 6.74 4.36

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
02 Jul 2001 0 15 0 24.9
0 25 0 26
0 15 0 21.5
0 15 0 34
0 40 0 47

Peers

Other companies within the same industry or sector that are comparable to Citurgia Biochemicals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sharda Cropchem Ltd 546.30 0.44 20.18 1427.29 35.34 0.55
Amines and Plasticizers Ltd 207.56 -3.66 27.75 870.42 361.94 0.24
Grauer and Weil (India) Ltd 115.60 0.00 32.66 3586.49 322.62 0.43
HP Adhesives Ltd 45.32 -3.04 21.28 1453.45 111.94 0.00

Company Info

YEAR EVENTS 1974 - The company was incorporated on 13th September at Mumbai. The company manufactures Citric Acid, Calcium Carbonate & Plasticizers. The company was promoted by John & E Sturdia Ltd., U.K. The Bombay Dyeing & Manufacturing Company Ltd., and Sturdia Chemicals Ltd., Mumbai. - The company entered into a technical collaboration with the company John & E. Sturge Ltd., in U.K. for manufacture of citric acid. - Towards the payment of imported plant and equipment, the Company was to allot to the collaborators 11,00,000 No. of equity shares of Rs 10 each. The collaborators were to supply the technical know-how for the manufacture of citric acid. - 10,001 shares subscribed for by the signatories to the Memorandum of Association; 10,44,317 shares allotted without payment in cash to John & E. Sturge, Ltd., U.K., 1,49,500 shares allotted to The Bombay Dyeing & Mfg. Co. Ltd.; 79,000 allotted to Chemicals, Ltd. and 2,12,999 shares allotted to directors and shareholders of Sturdia Chemicals, Ltd. 1978 - 15,04,183 shares issued at par through a prospectus dated 10.1.1997; 55,683 shares reserved for allotment to John & E. Sturge, Ltd., U.K. without payment in cash. 1,48,500 shares reserved to The Bombay Dyeing & Mfg. Co. Ltd. and 13,00,000 shares offered for public subscription during February 1977. 1983 - Jasper Investment Ltd. a wholly owned subsidiary of Sturdia chemicals Ltd. became subsidiary of the company on Sturdia's amalgamation with the company. - With effect from 1st April, Sturdia Chemicals Ltd., was amalgamated with the Company. As per the scheme of amalgamation, the company issued 3 equity shares of Rs 10 each for every two equity shares held in Sturdia Chemicals Ltd. (SCL), by the erstwhile shareholders of SCL. Totally 22,50,000 No. of equity shares of the Company were allotted to the erstwhile shareholders of Sturdia Chemicals Ltd., as on 2nd November, 1984. 1984 - 22,50,000 No. of equity shares issued without payment in cash to the members of Sturdia Chemicals, Ltd., on its merger with the Company. 1985 - The working was adversely affected due to lock-out at the Surat plant from 30th December. The lock out at the Surat plant was lifted on 15th May, 1986. - It was proposed to expand the installed capacity of citric acid from 5,000 tonnes to 8,000 tonnes per annum. Efforts were also being made for further modernisation of the Hrishikesh plant by installation of new equipment and instrumentation. 1987 - The Company successfully commissioned the anaerobic effluents discharged in the process of manufacturing citric acid at the Surat plant. - 18,68,735 No. of equity shares cancelled as per the scheme of reduction of capital. 1988 - The company issued 2,00,000-14% secured non-convertible debentures of Rs 100 each on private placement basis. These are redeemable at a premium of Rs 5 per debenture in 1995-96. 1989 - The Company privately placed with Army Group Insurance Directorate 1,15,000-14% secured non-convertible debentures of Rs 100 each. These are redeemable at premium of 5% in 1997. 1990 - The Company issued 4,95,000-14% secured non-convertible debentures of Rs 100 each. These are redeemable at a premium of Rs 5 per debenture in three equal annual instalments from 1996-97. 1991 - The Company successfully commissioned a 10 MT/hr fuel efficient oil-fired boiler at the Rishikesh plant. 1992 - The Company with a view to improve the yield and productivity of the fermentation process proposed to examine a new recovery technology. 1994 - The Company under took to modernise and expand the calcium carbonate plant. 1995 - A more productive strain of citric acid fermenting organism to reduce usage of raw material was introduced. The Company evaluated various proposals for debottlenecking plant capacity. - The Company received a sum of Rs 500.0 lakhs from ICICI sanctioned in participation with other financial institutions towards modernisation of its citric acid plant at Surat. 2002 -H C Pandya ceases to hold office of Director in Citurgia Biochemicals. 2004 -Mr. S R Lohokare has been appointed as Managing Director. 2013 -Change of registered office of the Company to "6/C, Ostwal Park, Building No. 4, CHSL, Near Jesal Park, Jain Temple, Bhayandar East, Thane, Mahararashtra - 401105". 2018 -The Company has splits its face value from Rs. 10/- to Rs. 2/-.

YEAR EVENTS 1974 - The company was incorporated on 13th September at Mumbai. The company manufactures Citric Acid, Calcium Carbonate & Plasticizers. The company was promoted by John & E Sturdia Ltd., U.K. The Bombay Dyeing & Manufacturing Company Ltd., and Sturdia Chemicals Ltd., Mumbai. - The company entered into a technical collaboration with the company John & E. Sturge Ltd., in U.K. for manufacture of citric acid. - Towards the payment of imported plant and equipment, the Company was to allot to the collaborators 11,00,000 No. of equity shares of Rs 10 each. The collaborators were to supply the technical know-how for the manufacture of citric acid. - 10,001 shares subscribed for by the signatories to the Memorandum of Association; 10,44,317 shares allotted without payment in cash to John & E. Sturge, Ltd., U.K., 1,49,500 shares allotted to The Bombay Dyeing & Mfg. Co. Ltd.; 79,000 allotted to Chemicals, Ltd. and 2,12,999 shares allotted to directors and shareholders of Sturdia Chemicals, Ltd. 1978 - 15,04,183 shares issued at par through a prospectus dated 10.1.1997; 55,683 shares reserved for allotment to John & E. Sturge, Ltd., U.K. without payment in cash. 1,48,500 shares reserved to The Bombay Dyeing & Mfg. Co. Ltd. and 13,00,000 shares offered for public subscription during February 1977. 1983 - Jasper Investment Ltd. a wholly owned subsidiary of Sturdia chemicals Ltd. became subsidiary of the company on Sturdia's amalgamation with the company. - With effect from 1st April, Sturdia Chemicals Ltd., was amalgamated with the Company. As per the scheme of amalgamation, the company issued 3 equity shares of Rs 10 each for every two equity shares held in Sturdia Chemicals Ltd. (SCL), by the erstwhile shareholders of SCL. Totally 22,50,000 No. of equity shares of the Company were allotted to the erstwhile shareholders of Sturdia Chemicals Ltd., as on 2nd November, 1984. 1984 - 22,50,000 No. of equity shares issued without payment in cash to the members of Sturdia Chemicals, Ltd., on its merger with the Company. 1985 - The working was adversely affected due to lock-out at the Surat plant from 30th December. The lock out at the Surat plant was lifted on 15th May, 1986. - It was proposed to expand the installed capacity of citric acid from 5,000 tonnes to 8,000 tonnes per annum. Efforts were also being made for further modernisation of the Hrishikesh plant by installation of new equipment and instrumentation. 1987 - The Company successfully commissioned the anaerobic effluents discharged in the process of manufacturing citric acid at the Surat plant. - 18,68,735 No. of equity shares cancelled as per the scheme of reduction of capital. 1988 - The company issued 2,00,000-14% secured non-convertible debentures of Rs 100 each on private placement basis. These are redeemable at a premium of Rs 5 per debenture in 1995-96. 1989 - The Company privately placed with Army Group Insurance Directorate 1,15,000-14% secured non-convertible debentures of Rs 100 each. These are redeemable at premium of 5% in 1997. 1990 - The Company issued 4,95,000-14% secured non-convertible debentures of Rs 100 each. These are redeemable at a premium of Rs 5 per debenture in three equal annual instalments from 1996-97. 1991 - The Company successfully commissioned a 10 MT/hr fuel efficient oil-fired boiler at the Rishikesh plant. 1992 - The Company with a view to improve the yield and productivity of the fermentation process proposed to examine a new recovery technology. 1994 - The Company under took to modernise and expand the calcium carbonate plant. 1995 - A more productive strain of citric acid fermenting organism to reduce usage of raw material was introduced. The Company evaluated various proposals for debottlenecking plant capacity. - The Company received a sum of Rs 500.0 lakhs from ICICI sanctioned in participation with other financial institutions towards modernisation of its citric acid plant at Surat. 2002 -H C Pandya ceases to hold office of Director in Citurgia Biochemicals. 2004 -Mr. S R Lohokare has been appointed as Managing Director. 2013 -Change of registered office of the Company to "6/C, Ostwal Park, Building No. 4, CHSL, Near Jesal Park, Jain Temple, Bhayandar East, Thane, Mahararashtra - 401105". 2018 -The Company has splits its face value from Rs. 10/- to Rs. 2/-.

Read More

Parent Organisation

Citurgia Biochemicals Ltd.

Founded

13/09/1974

Managing Director

NSE Symbol

CITURGIBIOEQ

FAQ

The current price of Citurgia Biochemicals Ltd is

The 52-week high for Citurgia Biochemicals Ltd is

The market capitalization of Citurgia Biochemicals Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Citurgia Biochemicals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Citurgia Biochemicals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Citurgia Biochemicals Ltd shares.

The CEO of Citurgia Biochemicals Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT